All clinical trials on the European Union Clinical Trials Register (EUCTR) must report their results in the registry within a year of completion. This site tracks who's doing this and who isn't. Learn more »
These trials completed more than 12 months ago and should have reported results. Some have, some have not.
These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.
These trials have problematic data on the registry. Details why »
|Status||Trial ID||Title||Completion date||Category|
|Not reported||2008-003336-38||The effect of Amiloride and Spironolacton on renophysiological and cardiovascular parametres in healthy patients||2010-07-27||due-trials|
|Not reported||2012-001131-31||Effekts of nebivolol on the nitric oxide system in patients with essentiel hypertension Effekten af nebivolol på NO-systemet hos patienter med essentiel hypertension||2013-09-12||due-trials|
|Not reported||2012-001169-33||Effects of tolvaptan on renal sodium and water handling and circulation during inhibition of the nitric oxide system in healthy subjects Effekten af tolvaptan på nyrernes behandling af vand og natr...||2013-03-25||due-trials|
|Not reported||2012-003815-71||The effect of furosemide on fluid volumes and biomarkers in urine for measurement of sodium and water channel activity in healthy subjects Effekten af furosemid på væskevoluminer og biomarkører i u...||2015-06-09||due-trials|
|Not reported||2013-003800-38||The effects of tolvaptan on renal handling of water and sodium, vasoactive hormones and circulatory system, during basal conditions and during inhibition of the nitric oxide system in healthy subject...||2014-10-17||due-trials|
|Reported results Terminated||2015-001903-30||Effect of tolvaptan on RBF and GFR in ADPKD Effekten af tolvaptan på RBF og GFR ved polycystisk nyresygdom||2017-12-13||due-trials|